🟢 CNTX is trading 9.5% up today, extending its rebound on positive CTIM-76 data and analyst support

CNTX is trading 9.5% up at $0.69 as it extends its rebound following last week’s CTIM-76 Phase 1 data and bullish analyst commentary.

• Shares are recovering from a June 15 collapse triggered by ovarian cancer trial data, with investors now reacting positively to interim CTIM-76 results.
• H.C. Wainwright and other firms have reiterated Buy ratings, fueling continued recovery buying despite a weak overall market environment.